NEW YORK (GenomeWeb) – GenDx today said that its NGSgo-AmpX for amplifying complete HLA genes for downstream sequencing has received CE marking.

The amplification primers can be used for Sanger sequencing and certain next-generation sequencing approaches and is the first CE-marked product for HLA typing for NGS, GenDx said. The product is platform-agnostic and suitable for the Illumina MiSeq, Ion Torrent PGM, and PacBio RS systems, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.